Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NCM · Common · CUSIP 21833P103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CRBP and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
21833P103
Market Cap
Small Cap
Business: Corbus Pharmaceuticals Holdings, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat life threatening (orphan) inflammatory-fibrotic diseases with clear unmet needs.

Company Contact

CEO
Yuval Cohen
CFO
Sean Moran
Headquarters
500 River Ridge Drive, Norwood, MA 02062
Phone
617-963-0100
Investor Relations
Christina Tartaglia, Stern IR · 212-632-1200 · christina.tartaglia@sternir.com
General Email
ir@corbuspharma.com
SEC EDGAR Filings
View filings »